Blood as a Substitute for Tumor Tissue in Detecting EGFR Mutations for Guiding EGFR TKIs Treatment of Nonsmall Cell Lung Cancer A Systematic Review and Meta-Analysis

Mao Chen; Yuan Jin-Qiu; Yang Zu-Yao; Fu Xiao-Hong; Wu Xin-Yin; Tang Jin-Ling

首页> 外文期刊>Medicine. >Blood as a Substitute for Tumor Tissue in Detecting EGFR Mutations for Guiding EGFR TKIs Treatment of Nonsmall Cell Lung Cancer A Systematic Review and Meta-Analysis

【24h】

Blood as a Substitute for Tumor Tissue in Detecting EGFR Mutations for Guiding EGFR TKIs Treatment of Nonsmall Cell Lung Cancer A Systematic Review and Meta-Analysis

机译：血液替代肿瘤组织检测EGFR突变以指导EGFR TKIs治疗非小细胞肺癌的系统评价和荟萃分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Tumor tissues are often absent or insufficient for testing epidermal growth factor receptor (EGFR) mutations to guide EGFR tyrosine kinase inhibitors (TKIs) treatment of patients with nonsmall cell lung cancer (NSCLC).

机译：肿瘤组织通常不存在或不足以测试表皮生长因子受体（EGFR）突变，以指导EGFR酪氨酸激酶抑制剂（TKIs）治疗非小细胞肺癌（NSCLC）患者。

著录项

来源
《Medicine.》 |2015年第21期|共10页
作者
Mao Chen; Yuan Jin-Qiu; Yang Zu-Yao; Fu Xiao-Hong; Wu Xin-Yin; Tang Jin-Ling;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Blood as a Substitute for Tumor Tissue in Detecting EGFR Mutations for Guiding EGFR TKIs Treatment of Nonsmall Cell Lung Cancer A Systematic Review and Meta-Analysis [J] . Mao Chen, Yuan Jin-Qiu, Yang Zu-Yao, Medicine. . 2015,第21期

机译：血液替代肿瘤组织检测EGFR突变以指导EGFR TKIs治疗非小细胞肺癌的系统评价和荟萃分析
2. BIM Gene Polymorphism Lowers the Efficacy of EGFR-TKIs in Advanced Nonsmall Cell Lung Cancer With Sensitive EGFR Mutations A Systematic Review and Meta-Analysis [J] . Huang Wu Feng, Liu Ai Hua, Zhao Hai Jin, Medicine. . 2015,第33期

机译：BIM基因多态性降低EGFR-TKIs在EGFR敏感突变的晚期非小细胞肺癌中的作用系统评价和荟萃分析
3. BIM Gene Polymorphism Lowers the Efficacy of EGFR-TKIs in Advanced Nonsmall Cell Lung Cancer With Sensitive EGFR Mutations A Systematic Review and Meta-Analysis [J] . Huang Wu Feng, Liu Ai Hua, Zhao Hai Jin, Medicine. . 2015,第33期

机译：BIM基因多态性降低EGFR-TKIS在先进的非富尔细胞肺癌中具有敏感EGFR突变的疗效，系统评价和荟萃分析
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. The Effectiveness of EGFR-TKIs in Treatment of Non-Small-Cell Lung Cancer: A Meta-Analysis. [D] . Li, Xiao. 2016

机译：EGFR-TKIs在非小细胞肺癌治疗中的有效性：一项荟萃分析。
6. Blood as a Substitute for Tumor Tissue in Detecting EGFR Mutations for Guiding EGFR TKIs Treatment of Nonsmall Cell Lung Cancer [O] . Chen Mao, Jin-Qiu Yuan, Zu-Yao Yang, -1

机译：血液替代肿瘤组织检测EGFR突变指导EGFR TKIs治疗非小细胞肺癌
7. Chinese Herbal Medicine Combined with EGFR-TKI in Advanced Non-small Cell Lung Cancer with EGFR Sensitive Mutation: a systematic review and meta-analysis protocol [O] . Yan Lu, Chenbing Sun, Yu Liu, 2020

机译：中草药联合EGFR-TKI在先进的非小细胞肺癌中，具有EGFR敏感突变：系统评价和META分析方案

Blood as a Substitute for Tumor Tissue in Detecting EGFR Mutations for Guiding EGFR TKIs Treatment of Nonsmall Cell Lung Cancer A Systematic Review and Meta-Analysis

摘要

著录项

相似文献

相关主题

期刊订阅